Brooklyn Immunotherapeuti Stock Options

BTX
 Stock
  

USD 0.57  0.02  3.64%   

Brooklyn Immunotherapeuti's option chain provides insight into all available option contracts written on Brooklyn Immunotherapeuti's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Brooklyn Immunotherapeuti's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Brooklyn option contract. View S&P 500 options
  
Refresh
Purchasing Brooklyn Immunotherapeuti options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Brooklyn calls. Remember, the seller must deliver Brooklyn Immunotherapeutics stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on Brooklyn Immunotherapeuti

Analyzing Brooklyn Immunotherapeuti's in-the-money options over time can help investors to take a profitable long position in Brooklyn Immunotherapeuti regardless of its overall volatility. This is especially true when Brooklyn Immunotherapeuti's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Brooklyn Immunotherapeuti's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Brooklyn Immunotherapeuti's stock while costing only a fraction of its price.
Brooklyn Immunotherapeuti's latest option contracts expiring on 2022-07-15 are carrying combined implied volatility of 35.99 with a put-to-call open interest ratio of 0.02 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-07-15. The current put volume is at 1, with calls trading at the volume of 33. This yields a 0.03 put-to-call volume ratio. The Brooklyn Immunotherapeuti option chain provides detailed quote and price information for the current Brooklyn Immunotherapeutics option contracts. It shows all of Brooklyn Immunotherapeuti's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-07-15 Option Contracts

Brooklyn Immunotherapeuti option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Brooklyn Immunotherapeuti's lending market. For example, when Brooklyn Immunotherapeuti's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Brooklyn Immunotherapeuti, he or she must hedge the risk by shorting Brooklyn Immunotherapeuti stock over its option's life.
The chart above shows Brooklyn Immunotherapeuti's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Brooklyn Immunotherapeuti's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Brooklyn Immunotherapeuti's option, there is no secondary market available for investors to trade.

Brooklyn Immunotherapeuti Maximum Pain Price across 2022-07-15 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Brooklyn Immunotherapeuti close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Brooklyn Immunotherapeuti's stock options are financial instruments that give investors the right to buy or sell shares of Brooklyn Immunotherapeuti common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Brooklyn stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Brooklyn Immunotherapeuti's stock price goes up or down, the stock options follow.
Continue to Trending Equities.
Please note that buying 'in-the-money' options on Brooklyn Immunotherapeuti lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Brooklyn Immunotherapeuti's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Brooklyn Immunotherapeuti contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Brooklyn Stock moves the wrong way.
Net Income Common Stock is likely to drop to about (125.5 M) in 2022

Brooklyn Current Options Market Mood

Brooklyn Immunotherapeuti's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Brooklyn Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Brooklyn Immunotherapeuti's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Brooklyn Immunotherapeuti's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Brooklyn Immunotherapeuti's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Brooklyn contract

Base on the Rule 16, the options market is currently suggesting that Brooklyn Immunotherapeutics will have an average daily up or down price movement of about 2.25% per day over the life of the 2022-07-15 option contract. With Brooklyn Immunotherapeuti trading at $0.57, that is roughly $0.0128. If you think that the market is fully incorporating Brooklyn Immunotherapeuti's daily price movement you should consider buying Brooklyn Immunotherapeutics options at the current volatility level of 35.99%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Brooklyn Immunotherapeuti Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends Income Statement Impact.
 Net Income Common Stock 
Share
      Timeline 

Brooklyn Immunotherapeuti Net Income Common Stock USD Over Time

Net Income Common Stock in USD; converted by US Dollar Exchange Rate.
 Net Income Common Stock USD 
Share
      Timeline 

Brooklyn Immunotherapeuti Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of Brooklyn Immunotherapeuti, understanding its historical liability is critical in projecting Brooklyn Immunotherapeuti's future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how Brooklyn Immunotherapeuti uses its financing power over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Brooklyn Immunotherapeuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Pair Trading with Brooklyn Immunotherapeuti

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brooklyn Immunotherapeuti position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brooklyn Immunotherapeuti will appreciate offsetting losses from the drop in the long position's value.

Brooklyn Immunotherapeuti Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Brooklyn Immunotherapeuti could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brooklyn Immunotherapeuti when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brooklyn Immunotherapeuti - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brooklyn Immunotherapeutics to buy it.
The correlation of Brooklyn Immunotherapeuti is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brooklyn Immunotherapeuti moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brooklyn Immunotherapeuti moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brooklyn Immunotherapeuti can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Brooklyn Immunotherapeuti information on this page should be used as a complementary analysis to other Brooklyn Immunotherapeuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Brooklyn Stock analysis

When running Brooklyn Immunotherapeuti price analysis, check to measure Brooklyn Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brooklyn Immunotherapeuti is operating at the current time. Most of Brooklyn Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Brooklyn Immunotherapeuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brooklyn Immunotherapeuti's price. Additionally, you may evaluate how the addition of Brooklyn Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Brooklyn Immunotherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brooklyn Immunotherapeuti. If investors know Brooklyn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brooklyn Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Brooklyn Immunotherapeuti is measured differently than its book value, which is the value of Brooklyn that is recorded on the company's balance sheet. Investors also form their own opinion of Brooklyn Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is Brooklyn Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brooklyn Immunotherapeuti's market value can be influenced by many factors that don't directly affect Brooklyn Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brooklyn Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Brooklyn Immunotherapeuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brooklyn Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.